Whitehawk Therapeutics, Inc. WHWK
3.13 USD +0.11 (+3.64%)
At closeNov 6, 2026, 4:01 PM EST
3.13 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
3.03 Day range 3.15
1.99 52-week range 5.10
- YTD
- +29.34%
- 1 year
- +49.05%
Financial health
Altman Z-Score
6.58 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 3
Valuation
P/E -7.3×
FY 2019 5y median -1.9× FY 2025
P/S 21.0×
FY 2019 5y median 19.0× FY 2025
P/B 1.1×
FY 2019 5y median 1.6× FY 2025
P/FCF -1.5×
FY 2019 5y median -1.5× FY 2025
EV/EBITDA -5.5×
FY 2019 5y median -1.8× FY 2025
EV/Sales 15.7×
FY 2019 5y median 15.7× FY 2025
FCF Yield -65.4%
FY 2019 5y median -65.4% FY 2025
Profitability
Gross Margin 89.4%
FY 2019 5y median -112.4% FY 2025
Operating Margin -1601.1%
FY 2019 5y median -411.9% FY 2025
Net Margin -288.3%
FY 2019 5y median -288.3% FY 2025
ROE -15.1%
FY 2019 5y median -62.5% FY 2025
ROIC -83.9%
FY 2019 5y median -77.9% FY 2025
ROA -13.7%
FY 2019 5y median -49.7% FY 2025
Growth (YoY)
Revenue -72.5%
FY 2019 FY 2025
Operating Income -69.6%
FY 2019 FY 2025
EPS (diluted) 86.0%
FY 2019 FY 2025
Free Cash Flow -60.1%
FY 2019 FY 2025
Financial Health
Current Ratio 10.3×
FY 2019 5y median 9.6× FY 2025
Quick Ratio 10.3×
FY 2019 5y median 9.5× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -273× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31